COST EFFECTIVENESS OF QUADRIVALENT INFLUENZA VACCINE OVER TRIVALENT VACCINE IN FRANCE

被引：4
|
作者：
Duru, G. [1 ]
Carrat, F. [2 ]
Pribil, C. [3 ]
Bricaire, F. [4 ]
Pujol, P. [3 ]
Robert, J. [5 ]
Lafuma, A. [5 ]
机构：
[1] Cyklad Grp, Rillieux La Pape, France
[2] Univ Paris 06, Paris, France
[3] GSK, Marly Le Roi, France
[4] Hosp La Pitie Salpetriere, Paris, France
[5] Cemka Eval, Bourg La Reine, France
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.2525
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN84
引用
收藏
页码：A678 / A678
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness of Adjuvanted Quadrivalent Influenza Vaccine for Adults over 65 in France
    Paccalin, Marc
    Gavazzi, Gaetan
    Berkovitch, Quentin
    Leleu, Henri
    Moreau, Romain
    Ciglia, Emanuele
    Burlet, Nansa
    Mould-Quevedo, Joaquin F.
    VACCINES, 2024, 12 (06)
  • [2] Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
    You, Joyce H. S.
    Ming, Wai-kit
    Chan, Paul K. S.
    BMC INFECTIOUS DISEASES, 2014, 14
  • [3] Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
    Joyce HS You
    Wai-kit Ming
    Paul KS Chan
    BMC Infectious Diseases, 14
  • [4] Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States
    de Boer, Pieter T.
    Crepey, Pascal
    Pitman, Richard J.
    Macabeo, Berengere
    Chit, Ayman
    Postma, Maarten J.
    VALUE IN HEALTH, 2016, 19 (08) : 964 - 975
  • [5] COST-EFFECTIVENESS OF QUADRIVALENT VERSUS TRIVALENT INFLUENZA VACCINE IN THE UNITED STATES
    De Boer, P. T.
    Pitman, R. J.
    Macabeo, B.
    Chit, A.
    Postma, M. J.
    Crepey, P.
    VALUE IN HEALTH, 2014, 17 (07) : A679 - A679
  • [6] Cost-effectiveness of quadrivalent versus trivalent influenza vaccine for elderly population in China
    Jiang, Minghuan
    Li, Pengchao
    Wang, Weihua
    Zhao, Mingyue
    Atif, Naveel
    Zhu, Shan
    Fang, Yu
    VACCINE, 2020, 38 (05) : 1057 - 1064
  • [7] COST-EFFECTIVENESS OF QUADRIVALENT INFLUENZA VACCINE HIGH DOSE VERSUS ADJUVANTED STANDARD DOSE TRIVALENT INFLUENZA VACCINE IN ENGLAND
    Gibbons, I
    Davidson, C.
    Clark-Wright, J.
    Miller, C.
    Carroll, S.
    Costa, M.
    Bricout, H.
    Alvarez, F. P.
    VALUE IN HEALTH, 2020, 23 : S554 - S554
  • [8] COST-EFFECTIVENESS ANALYSIS OF SWITCHING FROM A TRIVALENT TO A QUADRIVALENT INACTIVATED INFLUENZA VACCINE IN COLOMBIA
    Castro, R.
    Rueda, J. A.
    Drzewiecka, A.
    Gorecki, M.
    VALUE IN HEALTH, 2023, 26 (06) : S162 - S162
  • [9] Cost-Effectiveness Analysis of Switching from Trivalent to Quadrivalent Seasonal Influenza Vaccine in Argentina
    Uruena, Analia
    Micone, Paula
    Magneres, Cecilia
    Mould-Quevedo, Joaquin
    Giglio, Norberto
    VACCINES, 2021, 9 (04)
  • [10] Cost Utility of Switching From Trivalent to Quadrivalent Influenza Vaccine in Turkey
    Amiche, Amine
    Tanriover, Mine Durusu
    Bellier, Lucile
    Ugur, Baris
    Akin, Levent
    VALUE IN HEALTH REGIONAL ISSUES, 2021, 25 : 15 - 22
12345